Computational design of an epitope-specific Keap1 binding antibody using hotspot residues grafting and CDR loop swapping
暂无分享,去创建一个
Jiye Shi | Richard D. Taylor | Terry Baker | T. Ceska | Jiye Shi | A. Lawson | Terry S Baker | Xiaofeng Liu | L. Griffin | S. Coker | R. Adams | Ralph Adams | Tom Ceska | Alastair D. G. Lawson | Xiaofeng Liu | Laura Griffin | Shu-Fen Coker | T. Baker
[1] Timothy A. Whitehead,et al. Optimization of affinity, specificity and function of designed influenza inhibitors using deep sequencing , 2012, Nature Biotechnology.
[2] G. Murshudov,et al. Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.
[3] L. A. Clark,et al. An antibody loop replacement design feasibility study and a loop-swapped dimer structure. , 2008, Protein engineering, design & selection : PEDS.
[4] John McCafferty,et al. Beyond natural antibodies: the power of in vitro display technologies , 2011, Nature Biotechnology.
[5] J. Harper,et al. The Keap1-BTB Protein Is an Adaptor That Bridges Nrf2 to a Cul3-Based E3 Ligase: Oxidative Stress Sensing by a Cul3-Keap1 Ligase , 2004, Molecular and Cellular Biology.
[6] M. Vendruscolo,et al. Rational design of antibodies targeting specific epitopes within intrinsically disordered proteins , 2015, Proceedings of the National Academy of Sciences.
[7] Andrew C. R. Martin,et al. Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains. , 2008, Molecular immunology.
[8] Colin A. Smith,et al. Backrub-like backbone simulation recapitulates natural protein conformational variability and improves mutant side-chain prediction. , 2008, Journal of molecular biology.
[9] L. Mei,et al. Structural basis of agrin-LRP4-MuSK signaling. , 2012, Genes & development.
[10] Timothy A. Whitehead,et al. Computational Design of Proteins Targeting the Conserved Stem Region of Influenza Hemagglutinin , 2011, Science.
[11] E. Bourhis,et al. Wnt antagonists bind through a short peptide to the first β-propeller domain of LRP5/6. , 2011, Structure.
[12] A Tramontano,et al. Conformations of the third hypervariable region in the VH domain of immunoglobulins. , 1998, Journal of molecular biology.
[13] Gideon Schreiber,et al. Computational design of protein-protein interactions. , 2013, Current opinion in structural biology.
[14] R. Nussinov,et al. Conservation of polar residues as hot spots at protein interfaces , 2000, Proteins.
[15] D. Baker,et al. Design of a Novel Globular Protein Fold with Atomic-Level Accuracy , 2003, Science.
[16] David Baker,et al. Macromolecular modeling with rosetta. , 2008, Annual review of biochemistry.
[17] David Baker,et al. Role of the Biomolecular Energy Gap in Protein Design, Structure, and Evolution , 2012, Cell.
[18] A. Lawson,et al. Antibody-enabled small-molecule drug discovery , 2012, Nature Reviews Drug Discovery.
[19] K. Itoh,et al. Keap1 Recruits Neh2 through Binding to ETGE and DLG Motifs: Characterization of the Two-Site Molecular Recognition Model , 2006, Molecular and Cellular Biology.
[20] Jiye Shi,et al. SAbDab: the structural antibody database , 2013, Nucleic Acids Res..
[21] Jeffrey J. Gray,et al. SnugDock: Paratope Structural Optimization during Antibody-Antigen Docking Compensates for Errors in Antibody Homology Models , 2010, PLoS Comput. Biol..
[22] Hamid Tissire,et al. Structure-Guided Design of an Anti-dengue Antibody Directed to a Non-immunodominant Epitope , 2015, Cell.
[23] M. Lawrence,et al. Shape complementarity at protein/protein interfaces. , 1993, Journal of molecular biology.
[24] P. Wilson,et al. Tools to therapeutically harness the human antibody response , 2012, Nature Reviews Immunology.
[25] S. Tonegawa. Somatic generation of antibody diversity , 1983, Nature.
[26] Louis M. Weiner,et al. Monoclonal antibodies: versatile platforms for cancer immunotherapy , 2010, Nature Reviews Immunology.
[27] C. Deane,et al. ABangle: characterising the VH-VL orientation in antibodies. , 2013, Protein engineering, design & selection : PEDS.
[28] David Baker,et al. A de novo protein binding pair by computational design and directed evolution. , 2011, Molecular cell.
[29] P. Carter. Potent antibody therapeutics by design , 2006, Nature Reviews Immunology.
[30] M. Hannink,et al. Structure of the Keap1:Nrf2 interface provides mechanistic insight into Nrf2 signaling , 2006, The EMBO journal.
[31] D. Bartel,et al. Supporting Online Material Materials and Methods Som Text Figs. S1 to S14 Tables S1 to S8 References Crystal Structure of the Catalytic Core of an Rna-polymerase Ribozyme , 2022 .
[32] Peter Briggs,et al. A graphical user interface to the CCP4 program suite. , 2003, Acta crystallographica. Section D, Biological crystallography.
[33] Randy J. Read,et al. Overview of the CCP4 suite and current developments , 2011, Acta crystallographica. Section D, Biological crystallography.
[34] Luke N Robinson,et al. Redesign of a cross-reactive antibody to dengue virus with broad-spectrum activity and increased in vivo potency , 2013, Proceedings of the National Academy of Sciences.
[35] Haim J. Wolfson,et al. Geometric hashing: an overview , 1997 .
[36] L. Griffin,et al. Antibody fragments as tools in crystallography , 2011, Clinical and experimental immunology.
[37] M. Karplus,et al. Effective energy function for proteins in solution , 1999, Proteins.
[38] H. Hoogenboom,et al. Selecting and screening recombinant antibody libraries , 2005, Nature Biotechnology.
[39] Jens Meiler,et al. RosettaScripts: A Scripting Language Interface to the Rosetta Macromolecular Modeling Suite , 2011, PloS one.
[40] Julia M. Shifman,et al. Protein Engineering by Combined Computational and In Vitro Evolution Approaches. , 2016, Trends in biochemical sciences.
[41] A. Dickson,et al. A CHO cell line engineered to express XBP1 and ERO1‐Lα has increased levels of transient protein expression , 2013, Biotechnology progress.
[42] Randy J. Read,et al. Phaser crystallographic software , 2007, Journal of applied crystallography.
[43] Haruki Nakamura,et al. Computer-aided antibody design , 2012, Protein engineering, design & selection : PEDS.
[44] E. Söderlind,et al. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries , 2000, Nature Biotechnology.
[45] W. Saltzman,et al. Shining light on a new class of hydrogels , 2009, Nature Biotechnology.
[46] Luhua Lai,et al. Nonnatural protein–protein interaction-pair design by key residues grafting , 2007, Proceedings of the National Academy of Sciences.
[47] Ian W. Davis,et al. Structure validation by Cα geometry: ϕ,ψ and Cβ deviation , 2003, Proteins.
[48] Roland L. Dunbrack,et al. A new clustering of antibody CDR loop conformations. , 2011, Journal of molecular biology.
[49] Sarel J. Fleishman,et al. AbDesign: An algorithm for combinatorial backbone design guided by natural conformations and sequences , 2015, Proteins.
[50] X. Qiu,et al. Structures of protective antibodies reveal sites of vulnerability on Ebola virus , 2014, Proceedings of the National Academy of Sciences.
[51] Guohui Li,et al. Structural understanding of stabilization patterns in engineered bispecific Ig‐like antibody molecules , 2009, Proteins.
[52] R. Nussinov,et al. Protein–protein interactions: Structurally conserved residues distinguish between binding sites and exposed protein surfaces , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[53] J. Thornton,et al. PROCHECK: a program to check the stereochemical quality of protein structures , 1993 .
[54] Costas D. Maranas,et al. OptMAVEn – A New Framework for the de novo Design of Antibody Variable Region Models Targeting Specific Antigen Epitopes , 2014, PloS one.
[55] Y. Li,et al. Structure of a single-chain antibody variable domain (Fv) fragment complexed with a carbohydrate antigen at 1.7-A resolution. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[56] O. Zelphati,et al. Transcriptionally Active Polymerase Chain Reaction (TAP) , 2002, The Journal of Biological Chemistry.
[57] S Suhai,et al. Prediction of hypervariable CDR-H3 loop structures in antibodies. , 1995, Protein engineering.
[58] Tsutomu Ohta,et al. Structural basis for defects of Keap1 activity provoked by its point mutations in lung cancer. , 2006, Molecular cell.
[59] S J Wodak,et al. SFCHECK: a unified set of procedures for evaluating the quality of macromolecular structure-factor data and their agreement with the atomic model. , 1999, Acta crystallographica. Section D, Biological crystallography.
[60] Bruce Tidor,et al. Computational design of antibody-affinity improvement beyond in vivo maturation , 2007, Nature Biotechnology.
[61] Burkhard Rost,et al. Protein–Protein Interaction Hotspots Carved into Sequences , 2007, PLoS Comput. Biol..
[62] David Baker,et al. Hotspot-centric de novo design of protein binders. , 2011, Journal of molecular biology.
[63] Andrew C. Chan,et al. Therapeutic antibodies for autoimmunity and inflammation , 2010, Nature Reviews Immunology.
[64] B. Kuhlman,et al. A comparison of successful and failed protein interface designs highlights the challenges of designing buried hydrogen bonds , 2013, Protein science : a publication of the Protein Society.
[65] A. Shukla,et al. Methodological advances: the unsung heroes of the GPCR structural revolution , 2015, Nature Reviews Molecular Cell Biology.
[66] Dima Kozakov,et al. The FTMap family of web servers for determining and characterizing ligand-binding hot spots of proteins , 2015, Nature Protocols.
[67] Haruki Nakamura,et al. Structural classification of CDR‐H3 in antibodies , 1996, FEBS letters.
[68] A. Lesk,et al. Standard conformations for the canonical structures of immunoglobulins. , 1997, Journal of molecular biology.
[69] D. Spring,et al. The Application of Ligand-Mapping Molecular Dynamics Simulations to the Rational Design of Peptidic Modulators of Protein-Protein Interactions. , 2015, Journal of chemical theory and computation.
[70] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[71] Jeffrey J. Gray,et al. Toward high‐resolution homology modeling of antibody Fv regions and application to antibody–antigen docking , 2009, Proteins.